生物
瘤胃球菌
阿克曼西亚
肠道菌群
厚壁菌
某种肠道细菌
微生物群
益生元
拟杆菌
肠易激综合征
双歧杆菌
疾病
乳酸菌
免疫学
生物信息学
医学
细菌
内科学
食品科学
遗传学
16S核糖体RNA
作者
Ronald D. Hills,Benjamin Pontefract,Hillary R. Mishcon,Cody A. Black,Steven C. Sutton,Cory R. Theberge
出处
期刊:Nutrients
[MDPI AG]
日期:2019-07-16
卷期号:11 (7): 1613-1613
被引量:781
摘要
The gut microbiome plays an important role in human health and influences the development of chronic diseases ranging from metabolic disease to gastrointestinal disorders and colorectal cancer. Of increasing prevalence in Western societies, these conditions carry a high burden of care. Dietary patterns and environmental factors have a profound effect on shaping gut microbiota in real time. Diverse populations of intestinal bacteria mediate their beneficial effects through the fermentation of dietary fiber to produce short-chain fatty acids, endogenous signals with important roles in lipid homeostasis and reducing inflammation. Recent progress shows that an individual's starting microbial profile is a key determinant in predicting their response to intervention with live probiotics. The gut microbiota is complex and challenging to characterize. Enterotypes have been proposed using metrics such as alpha species diversity, the ratio of Firmicutes to Bacteroidetes phyla, and the relative abundance of beneficial genera (e.g., Bifidobacterium, Akkermansia) versus facultative anaerobes (E. coli), pro-inflammatory Ruminococcus, or nonbacterial microbes. Microbiota composition and relative populations of bacterial species are linked to physiologic health along different axes. We review the role of diet quality, carbohydrate intake, fermentable FODMAPs, and prebiotic fiber in maintaining healthy gut flora. The implications are discussed for various conditions including obesity, diabetes, irritable bowel syndrome, inflammatory bowel disease, depression, and cardiovascular disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI